EKF Diagnostics Holdings plc

24.40pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:EKFHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 7.38%
Div yield —
ROE 4.03%
Medical Devices
Beta (5Y) 0.50
PE TTM 42.87
TSR TTM (7.40%)
Mkt cap £104.5M
ROIC 5.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
24p
(3.33%)
309.62%
Hold 12|12|11|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.36
0.36
0.34
0.34
22.93%
11.80%
(2.02%)
(3.28%)
Revenue£M
12.90
13.59
13.65
13.64
6.56%
15.73%
16.07%
10.63%
Peers (US$140.6M)
Cap (US$)
PE
362.4M
39.25x
21.38M
56.41x
142.4M
7.418x
Capital
TTM
5Y
10Y
Leveragex
0.517
3.621
3.346
EBIT/Intx
0.288
0.105
0.106
Own earn%
18.41
(7.98)
(16.59)
Sh yield%
35.84
17.20
20.62
Owners
Insiders/Inst%
13.52
31.70
Short interest%
3.48
SBC / revenue%
3.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
2